" class="no-js "lang="en-US"> XWPharma - Medtech Alert
Thursday, March 30, 2023
XWPharma | Pharmtech Focus


About XWPharma


We are a biotech with a neuroscience pipeline of internally discovered novel small molecule drug candidates focused on sleep, neuropysch and other underserved neurological conditions.

Related Story

XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

October 19 2021

Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the […]